roundhill glp-1 & weight loss etf OZEM: Active Management Crucial in the Drug Landscape New Year's Resolutions: Lose Weight

The primary diagnosis code should reflect the clinical manifestation (e.g., K85.3 for drug-induced pancreatitis), followed by an external cause code from the Y40Y59 range to indicate the medication involved

E11.42 (polyneuropathy) E11.3212 (moderate NPDR, left eye, no macular edema) E11.12 (diabetic CKD stage 3) N18.3 (CKD stage 3, required companion) Z79.4 (long-term insulin, only Z79.4 needed when on both insulin and oral agents per official guidelines) Note: Z79.84 is NOT added here because per ICD-10-CM Official Guidelines, when a patient uses both insulin and oral hypoglycemics, only Z79.4 is assigned

Interestingly, univariate analysis did not identify differences in T2D duration between responder and non-responders (Table 3)

doi: 10.1101/2024.01.18.24301500 [DOI] [Google Scholar] 27.Its not just obesity

In the future, approaches such as this may help to define physiologic and mechanistic causes for the differences in GLP-1 M responsiveness